Efficacy and Safety of Valsartan and Aliskiren Combination Therapy in Patients with Diabetic Nephropathy and Hypertensio
Not Applicable
- Conditions
- Type 2 diabetes with nephropathy and hypertension
- Registration Number
- JPRN-UMIN000003741
- Lead Sponsor
- Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1)Taking corticosteroid 2)Secondary hypertension or maliganant hypertension 3)Acute myocardial infarction within 24 weeks 4)Stroke within 12 weeks 5)Severe ventricular tachyarrhythmia or advanced AV block 6)Cardiogenic shock 7)Bilateral renal artery stenosis 8)Sever liver dysfunction 9)Severe hematopoietic disorder or carcinoma 10)Type 1 diabetes 11)Taking cyclosporine A 12)Pregnancy 13)Drug allergy 14) not qualified
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method